Home Latest Articles

Latest Articles

Latest

Oral Sores and Cancer Treatment

Alisa Cooper Wechsler -

First-line Treatment with Pembrolizumab

Peter Hofland, Ph.D -

First Patients Enrolled in Landmark Lung Cancer Tri-Therapy Clinical Trial

Peter Hofland, Ph.D -

Charitable Efforts Know No Boundaries When Helping the Underserved? Stakeholders Strive...

Eric T. Rosenthal -

Anti-Leukemic Activity and Safety Data for Gilteritinib in Relapsed

Peter Hofland, Ph.D -
Annual Meeting of the American Society of Clinical Oncology at McCormick Place in Chicago, Ill.

Eric Rosenthal Reports: Placing Cancer Fear in its Proper Perspective

Eric T. Rosenthal -

Palbociclib may have Wider Applicability in Targeting Cancer

Peter Hofland, Ph.D -

First Immunotherapy Expected for the treatment of Malignant Pleural Mesothelioma

Peter Hofland, Ph.D -

Encouraging Breakthrough in the Treatment of Patients with Multiple Myeloma

Peter Hofland, Ph.D -
Attendees during the day at the American Society of Clinical Oncology (ASCO) Courtesy: ? ASCO/Scott Morgan.

Alectinib More Effective Compared to Current Standard of Care Crizotinib

Peter Hofland, Ph.D -
12Page 1 of 2

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.